semaglutide efficacy and safety of once-weekly versus once-daily sitagliptin as an add-on to metformin, thiazolidinediones, or both, in patients with type 2 diabetes (SUSTAIN 2): a 56-week, double-blind, phase 3a, randomised trial Efficacy of tirzepatide versus semaglutide

The most common adverse events with orforglipron were gastrointestinal in nature and included nausea, diarrhea, constipation, vomiting and dyspepsia

New persistent headaches, especially with visual symptoms (consistent with intracranial-hypertension warning in the Increlex label)

NIH Blood Bank

V glutathione l mt cht chng oxy ha cc mnh cho nn mi t bo ca c th khe mnh hn u cn phi c n

Probability's nature and nature's probability

(Both medications are also approved to reduce cardiovascular risk in people with known heart disease and either type 2 diabetes or obesity.) Semaglutide belongs to a category of prescription medications known as GLP-1s